Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
89371-37-9CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)[O-]KLZWOWYOHUKJIG-BPUTZDHNSA-N89371-37-9BeschreibungImidapril is a new ACE inhibitor launched in Japan as a once-daily therapy for hypertension. Its active metabolite has more potent inhibitory effects on all tissue ACES from spontaneously hypertensive rats (SHRs) and Wistar Kyoto rats (WKYs) than many other ACE inhibitors including enalapril and captopril. It has a very long duration of action. In strokeprone spontaneously hypertensive rats (SHRSP), imidapril is effective in stroke prevention at a considerably lower dose than enalapril. This stroke preventive effect has been suggested to be primarily by an indirect mechanism related to the amelioration of kidney dysfunction.
VerwendenAngiotensin converting enzyme (ACE) inhibitor. Antihypertensive
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…